Schedule 13G ownership disclosure

Lyell Immunopharma Inc

Common Stock, $0.0001 par value per share · CUSIP: 55083R203

Event date: 2025-07-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Gates Frontier, LLC

    Shares: 1,040,964.00 · Class: 5.6%

  • William H. Gates III

    Shares: 1,040,964.00 · Class: 5.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-073122
Form type
SCHEDULE 13G
Filer
Gates Frontier, LLC
CIK
CIK 1580115
Filed
Aug 01, 2025
Reporting period
Jul 25, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub